83.91MMarket Cap-2229P/E (TTM)
8.500High8.030Low6.97KVolume8.500Open8.490Pre Close58.04KTurnover0.13%Turnover RatioLossP/E (Static)10.27MShares12.77052wk High17.24P/B44.45MFloat Cap2.96052wk Low--Dividend TTM5.44MShs Float263.000Historical High--Div YieldTTM5.54%Amplitude2.960Historical Low8.333Avg Price1Lot Size
Elicio Therapeutics Stock Forum
NEWS
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
Elicio Therapeutics revealed preliminary data from their AMPLIFY-7P Phase 1a study of ELI-002 7P at the ASCO 2024 Annual Meeting. The cancer vaccine candidate, targeting mKRAS-driven solid tumors, showed promising results. ELI-002 7P was well tolerated and induced a significant (~100x...
No comment yet